Project Details
Development of preferential HDAC6 inhibitors and degraders to immunosensitize myeloid leukemia cells
Subject Area
Pharmacy
Term
since 2026
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 574430877
No abstract available
DFG Programme
Research Grants
International Connection
USA
Cooperation Partner
Professor David W. Christianson, Ph.D.
